Mikhail Blagosklonny – A Leading Authority in Oncology and Aging Research

With cases of cancer on the rise, oncologists around the world have been searching far and wide for cures. And, while the future of this mission seems bright, most of these researchers are still progressive. However, among those that have made revolutionary discoveries is Mikhail Blagosklonny.Mikhail Blagosklonny is a leading oncologist who has dedicated his life to finding solutions to cancer and aging. His discoveries have set the groundwork for future research that may actually provide a solution. Here is a brief insight into Mikhail Blagosklonny’s academic and occupational profile.

Educational Background

Mikhail Blagosklonny attended the Pavlov State Medical University of St. Petersburg. During his time at the university, his passion and excellence in oncology saw him not only learn but also teach. He graduated from the university with a Ph.D. in experimental medicine as well as an M.D. in Internal Medicine.

Career

Mikhail Blagosklonny began his career long before leaving Pavlov State Medical University of St. Petersburg. His expertise on the subject, coupled with his passion to further existing research, saw him earn a position as a junior professor in the university.However, he soon moved on from the university after graduating and naturally landed better occupations. His first occupation after graduating was as a professor of oncology at the New York Medical College in 2002. A few years later, Mikhail Blagosklonny changed jobs when he accepted the position of Senior Scientist at the Ordway Research Institute in Albany, New York. It is here where he began his fascination with research.Mikhail Blagosklonny is currently a professor of oncology at the Roswell Park Cancer Institute. The institute is one of the leading cancer research centers in the world – it was the first institute certified to treat cancer and conduct research in the United States, and it is the only institute in New York that bears the title of Comprehensive Cancer Center. The institute is renowned for its development of cancer medication and therapy; hence its research facilities have been instrumental in Mikhail Blagosklonny’s research.

Editorial Occupation

As a researcher, Mikhail Blagosklonny is fascinated with other scientists’ research. To this end, he is very involved in various oncology journals and is even an editor at Oncotarget. He has thus far published over 200 reports on different scientific journals, and most of them are widely used as reference sources and guides for further research.

Mikhail Blagosklonny’s Research

Mikhail Blagosklonny’s research into cancer and aging is one of the most promising. It is based on the Target of Rapamycin (TOR). It has been discovered that, if manipulated, then TOR can be used to adjust aging and isolate and eliminate cancer cells in the body. It can be used to regulate many important aspects including nutrient intake, motility, cell survival, and protein synthesis, among many others.However, most of his research still remains a theory until it can be cleared for testing on patients. Currently, tests are being conducted on lab mice to determine whether the theories are viable enough.

Comments are closed.